BioMar Shares Jump After Morgan Stanley Starts Coverage; Investors Eye Cost Pressures
BioMar shares climbed 3.1% to 115.3 Danish crowns following Morgan Stanley's initiation of coverage with an equal-weight rating and a 121-crown price target. The move provided institutional validation for a stock that had been trading below its 108-crown IPO price in recent weeks. While Morgan Stanley flagged significant raw material inflation in Q…